tranexamic acid has been researched along with Anemias, Iron-Deficiency in 9 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To assess whether use of tranexamic acid is associated with an increased risk of venous thromboembolism (VTE)." | 7.75 | The risk of venous thromboembolism associated with the use of tranexamic acid and other drugs used to treat menorrhagia: a case-control study using the General Practice Research Database. ( Alfredsson, L; Kieler, H; Seaman, H; Sundström, A, 2009) |
| "To assess whether use of tranexamic acid is associated with an increased risk of venous thromboembolism (VTE)." | 3.75 | The risk of venous thromboembolism associated with the use of tranexamic acid and other drugs used to treat menorrhagia: a case-control study using the General Practice Research Database. ( Alfredsson, L; Kieler, H; Seaman, H; Sundström, A, 2009) |
| "Menorrhagia is defined as menstrual periods lasting more than 7 days and/or involving blood loss greater than 80ml." | 2.46 | Clinical practice guidelines on menorrhagia: management of abnormal uterine bleeding before menopause. ( Agostini, A; Bazot, M; Brailly-Tabard, S; Brun, JL; Chabbert-Buffet, N; Cravello, L; De Raucourt, E; Fauconnier, A; Fernandez, H; Gervaise, A; Golfier, F; Gompel, A; Gondry, J; Graesslin, O; Huchon, C; Lucot, JP; Marret, H; Plu-Bureau, G; Roman, H, 2010) |
| "Tranexamic acid (TXA) was used intraoperatively for 30%, red blood cells (RBC) were transfused for 20% and 55 patients (37%) received IV iron." | 1.62 | Administration of intravenous iron and tranexamic acid in the management of postoperative iron deficiency anaemia following free flap reconstruction: re-audit. ( Lowe, D; McLean, A; Rogers, SN, 2021) |
| "Medroxyprogesterone acetate treatment for her dysfunctional uterine bleeding was unsuccessful." | 1.32 | Menorrhagia due to a qualitative deficiency of plasminogen activator inhibitor-1: case report and literature review. ( Osswald, M; Repine, T, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 3 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Jung, HJ | 1 |
| Kang, MW | 1 |
| Lee, JH | 1 |
| Lee, JK | 1 |
| Kim, JI | 1 |
| McLean, A | 1 |
| Lowe, D | 1 |
| Rogers, SN | 1 |
| DeLoughery, TG | 1 |
| Sundström, A | 1 |
| Seaman, H | 1 |
| Kieler, H | 1 |
| Alfredsson, L | 1 |
| Marret, H | 1 |
| Fauconnier, A | 1 |
| Chabbert-Buffet, N | 1 |
| Cravello, L | 1 |
| Golfier, F | 1 |
| Gondry, J | 1 |
| Agostini, A | 1 |
| Bazot, M | 1 |
| Brailly-Tabard, S | 1 |
| Brun, JL | 1 |
| De Raucourt, E | 1 |
| Gervaise, A | 1 |
| Gompel, A | 1 |
| Graesslin, O | 1 |
| Huchon, C | 1 |
| Lucot, JP | 1 |
| Plu-Bureau, G | 1 |
| Roman, H | 1 |
| Fernandez, H | 1 |
| Muse, K | 1 |
| Mabey, RG | 1 |
| Waldbaum, A | 1 |
| Gersten, JK | 1 |
| Adomako, TL | 1 |
| Repine, T | 1 |
| Osswald, M | 1 |
| Amarapurkar, DN | 1 |
| Patel, ND | 1 |
| Hope, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| IV Tranexamic Acid Prior to Hysterectomy for Reduction of Intraoperative Blood Loss: A Randomized Placebo-Controlled Trial[NCT02911831] | Early Phase 1 | 71 participants (Actual) | Interventional | 2016-11-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for tranexamic acid and Anemias, Iron-Deficiency
| Article | Year |
|---|---|
Transfusion replacement strategies in Jehovah's Witnesses and others who decline blood products.
Topics: Anemia, Iron-Deficiency; Blood Component Transfusion; Hematinics; Humans; Iron; Iron Deficiencies; J | 2020 |
Clinical practice guidelines on menorrhagia: management of abnormal uterine bleeding before menopause.
Topics: Adolescent; Adult; Anemia, Iron-Deficiency; Blood Coagulation Disorders; Contraceptives, Oral, Combi | 2010 |
7 other studies available for tranexamic acid and Anemias, Iron-Deficiency
| Article | Year |
|---|---|
The Association of Intravenous Iron Administered the Day before Total Knee Arthroplasty with Postoperative Anemia and Functional Recovery.
Topics: Anemia; Anemia, Iron-Deficiency; Arthroplasty, Replacement, Knee; Ferritins; Hemoglobins; Humans; Re | 2023 |
Administration of intravenous iron and tranexamic acid in the management of postoperative iron deficiency anaemia following free flap reconstruction: re-audit.
Topics: Administration, Intravenous; Aged; Anemia, Iron-Deficiency; Antifibrinolytic Agents; Female; Free Ti | 2021 |
The risk of venous thromboembolism associated with the use of tranexamic acid and other drugs used to treat menorrhagia: a case-control study using the General Practice Research Database.
Topics: Adolescent; Adult; Anemia, Iron-Deficiency; Antifibrinolytic Agents; Databases, Factual; Epidemiolog | 2009 |
Tranexamic acid increases hemoglobin and ferritin levels in women with heavy menstrual bleeding.
Topics: Adolescent; Adult; Anemia, Iron-Deficiency; Antifibrinolytic Agents; Female; Ferric Compounds; Ferri | 2012 |
Menorrhagia due to a qualitative deficiency of plasminogen activator inhibitor-1: case report and literature review.
Topics: Adult; Anemia, Iron-Deficiency; Antifibrinolytic Agents; Blood Coagulation Tests; Female; Hemorrhagi | 2004 |
Gastric antral vascular ectasia (GAVE) syndrome.
Topics: Aged; Anemia, Iron-Deficiency; Chronic Disease; Disease Progression; Female; Gastric Antral Vascular | 2004 |
10 minute consultation: menorrhagia.
Topics: Anemia, Iron-Deficiency; Anti-Inflammatory Agents, Non-Steroidal; Antifibrinolytic Agents; Clinical | 2000 |